1. Home
  2. GME vs BMRN Comparison

GME vs BMRN Comparison

Compare GME & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GameStop Corporation

GME

GameStop Corporation

HOLD

Current Price

$25.23

Market Cap

12.1B

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$56.58

Market Cap

12.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GME
BMRN
Founded
1996
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Electronics Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
12.3B
IPO Year
2005
1999

Fundamental Metrics

Financial Performance
Metric
GME
BMRN
Price
$25.23
$56.58
Analyst Decision
Buy
Analyst Count
0
28
Target Price
N/A
★ $91.59
AVG Volume (30 Days)
★ 9.3M
2.2M
Earning Date
12-08-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 133.33
N/A
EPS
★ 1.17
0.77
Revenue
★ $3,629,900,000.00
$1,313,646,000.00
Revenue This Year
$7.49
$21.42
Revenue Next Year
$11.01
$14.51
P/E Ratio
★ $22.49
$71.70
Revenue Growth
N/A
★ 17.62
52 Week Low
$17.79
$49.26
52 Week High
$28.30
$70.98

Technical Indicators

Market Signals
Indicator
GME
BMRN
Relative Strength Index (RSI) 52.54 44.56
Support Level $21.23 $53.89
Resistance Level $25.34 $57.88
Average True Range (ATR) 1.22 1.58
MACD -0.24 0.29
Stochastic Oscillator 26.76 65.80

Price Performance

Historical Comparison
GME
BMRN

About GME GameStop Corporation

GameStop Corp offers games, collectibles, and entertainment products through its stores and ecommerce platforms. Its products include Hardware and accessories offering new and pre-owned gaming platforms from the console manufacturers, Software offering new and pre-owned gaming software for current and certain prior generation consoles and sell a wide range of in-game digital currency, digital downloadable content and full-game downloads, and Collectibles consist of apparel, toys, trading cards, gadgets and other retail products for pop culture and technology enthusiasts and collectibles related services, such as submission services for the authentication and grading of trading cards. The company operates its business in three geographic segments: the United States, Australia, and Europe.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: